English

PHARMAPRINT INC

EDGAR

Quarterly report (10-Q) · filed 2001-02-13

20 filing records in this dataset, filed from 1996-09-26 to 2001-02-13. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

1 USD

2000-03-31 · USD

Exact inputs and evidence

Revenue: 6492868 USD Source
Revenue: 6492867 USD Source

Net margin

-1,029,224,400%

2000-03-31 · %

Exact inputs and evidence

Net Income: -27595904 USD Source
Net Income: -17303660 USD Source
Revenue: 6492868 USD Source
Revenue: 6492867 USD Source

Operating cash flow

-1.41 million USD

2000-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: -7706936 USD Source
Operating Cash Flow: -6301359 USD Source

Cash and cash equivalents: 152 thousand USD 2000-12-31 Source
Exact value

151901 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-13.4 million USD

2000-01-01 – 2000-12-31

Exact inputs and evidence

Net income: -27595904 USD · 1999-04-01 – 2000-03-31 Source
Net income: -17303660 USD · 1999-04-01 – 1999-12-31 Source
Net income: -524717 USD · 2000-04-01 – 2000-06-30 Source
Net income: -1935541 USD · 2000-07-01 – 2000-09-30 Source
Net income: -682643 USD · 2000-10-01 – 2000-12-31 Source

Operating cash flow

-2.98 million USD

2000-01-01 – 2000-12-31

Exact inputs and evidence

Operating cash flow: -7706936 USD · 1999-04-01 – 2000-03-31 Source
Operating cash flow: -6301359 USD · 1999-04-01 – 1999-12-31 Source
Operating cash flow: -920378 USD · 2000-04-01 – 2000-06-30 Source
Operating cash flow: -1088136 USD · 2000-04-01 – 2000-09-30 Source
Operating cash flow: -920378 USD · 2000-04-01 – 2000-06-30 Source
Operating cash flow: -1572072 USD · 2000-04-01 – 2000-12-31 Source
Operating cash flow: -1088136 USD · 2000-04-01 – 2000-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2001-02-13.

Financial data available through: 2000-03-31.

Coverage by financial measure

Revenue: 4 of 11 periods available· newest 2000-03-31
Operating income: 3 of 11 periods available· newest 2000-03-31
Net income: 4 of 11 periods available· newest 2000-03-31
Operating cash flow: 4 of 11 periods available· newest 2000-03-31
Capital expenditure: 3 of 11 periods available· newest 2000-03-31
Total assets: 3 of 11 periods available· newest 1999-03-31
Total liabilities: 1 of 11 periods available· newest 2000-03-31
Current assets: 4 of 11 periods available· newest 2000-03-31
Current liabilities: 4 of 11 periods available· newest 2000-03-31
Cash and cash equivalents: 4 of 11 periods available· newest 2000-03-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-70.9%

Prior period

USD 22.29 million

1998-04-01 – 1999-03-31
Current period

USD 6.49 million

1999-04-01 – 2000-03-31

Exact inputs and evidence

6492868 − 22289063 = -15796195 USD

22289063 USD · 1998-04-01 – 1999-03-31
Inspect prior input Prior source
6492868 USD · 1999-04-01 – 2000-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · PHARMAPRINT INC · 2000-03-31 PHARMAPRINT INC (edgar:935155) Year-over-year change in Revenue: -15796195 USD Concept: fundies:Revenue Period: 1999-04-01 to 2000-03-31 Values: Latest reported Published: 2026-11-02T17:09:03Z Snapshot: 8f4a855d1da598c97fea856ec291401e8f8c230fd62edd4d12fc3e4f6d9bca21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/935155?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 6492868 USD (1999-04-01 to 2000-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/935155/0001095811-00-002886.txt#2253 Input fundies:Revenue: 22289063 USD (1998-04-01 to 1999-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/935155/0001095811-00-002886.txt#2253
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 12.81 million

Prior period

−USD 14.78 million

1998-04-01 – 1999-03-31
Current period

−USD 27.6 million

1999-04-01 – 2000-03-31

Exact inputs and evidence

-27595904 − -14782860 = -12813044 USD

-14782860 USD · 1998-04-01 – 1999-03-31
Inspect prior input Prior source
-27595904 USD · 1999-04-01 – 2000-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · PHARMAPRINT INC · 2000-03-31 PHARMAPRINT INC (edgar:935155) Year-over-year change in Net income: -12813044 USD Concept: fundies:NetIncome Period: 1999-04-01 to 2000-03-31 Values: Latest reported Published: 2026-11-02T17:09:03Z Snapshot: 8f4a855d1da598c97fea856ec291401e8f8c230fd62edd4d12fc3e4f6d9bca21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/935155?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -27595904 USD (1999-04-01 to 2000-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/935155/0001095811-00-002886.txt#2479 Input fundies:NetIncome: -14782860 USD (1998-04-01 to 1999-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/935155/0001095811-00-002886.txt#2479
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 15.53 million

Prior period

−USD 23.23 million

1998-04-01 – 1999-03-31
Current period

−USD 7.71 million

1999-04-01 – 2000-03-31

Exact inputs and evidence

-7706936 − -23233200 = 15526264 USD

-23233200 USD · 1998-04-01 – 1999-03-31
Inspect prior input Prior source
-7706936 USD · 1999-04-01 – 2000-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · PHARMAPRINT INC · 2000-03-31 PHARMAPRINT INC (edgar:935155) Year-over-year change in Operating cash flow: 15526264 USD Concept: fundies:OperatingCashFlow Period: 1999-04-01 to 2000-03-31 Values: Latest reported Published: 2026-11-02T17:09:03Z Snapshot: 8f4a855d1da598c97fea856ec291401e8f8c230fd62edd4d12fc3e4f6d9bca21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/935155?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -7706936 USD (1999-04-01 to 2000-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/935155/0001095811-00-002886.txt#2495 Input fundies:OperatingCashFlow: -23233200 USD (1998-04-01 to 1999-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/935155/0001095811-00-002886.txt#2495
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-10.9%

Prior period

USD 886,840

1998-04-01 – 1999-03-31
Current period

USD 790,571

1999-04-01 – 2000-03-31

Exact inputs and evidence

790571 − 886840 = -96269 USD

886840 USD · 1998-04-01 – 1999-03-31
Inspect prior input Prior source
790571 USD · 1999-04-01 – 2000-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · PHARMAPRINT INC · 2000-03-31 PHARMAPRINT INC (edgar:935155) Year-over-year change in Capital expenditure: -96269 USD Concept: fundies:CapitalExpenditure Period: 1999-04-01 to 2000-03-31 Values: Latest reported Published: 2026-11-02T17:09:03Z Snapshot: 8f4a855d1da598c97fea856ec291401e8f8c230fd62edd4d12fc3e4f6d9bca21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/935155?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 790571 USD (1999-04-01 to 2000-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/935155/0001095811-00-002886.txt#2499 Input fundies:CapitalExpenditure: 886840 USD (1998-04-01 to 1999-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/935155/0001095811-00-002886.txt#2499
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2000 1999-04-01 – 2000-03-31

Revenue USD 6.49 million 100% of revenue
Cost of revenue USD 11.52 million 177% of revenue
Operating expenses USD 24.35 million 375% of revenue
Operating income −USD 29.37 million −452% of revenue
Tax, interest and other Derived −USD 1.78 million −27% of revenue
Net income −USD 27.6 million −425% of revenue

Cash

Operating cash flow −USD 7.71 million −119% of revenue
Capital expenditure USD 790,571 12% of revenue
Free cash flow Derived −USD 8.5 million −131% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1997 Not shown: operating income or net income is not reported.
1998 Not shown: operating income or net income is not reported.
1999 Operating loss: operating costs were 166% of revenue.
2000 Operating loss: operating costs were 552% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1997 1996-04-01 – 1997-03-31	0	Unavailable	Unavailable	Unavailable	-11232852	Unavailable	Source 1996-04-01 – 1997-03-31: 0 USD Inspect Revenue Open source 1996-04-01 – 1997-03-31: -11232852 USD Inspect Net Income Open source 1996-04-01 – 1997-03-31: -5366039 USD Inspect Operating Cash Flow Open source
1998 1997-04-01 – 1998-03-31	0	18115402 Derived	-18115402	0 Derived	-18115402	-11053991 Derived	Source 1997-04-01 – 1998-03-31: 0 USD Inspect Revenue Open source 1997-04-01 – 1998-03-31: -18115402 USD Inspect Operating Income Open source 1997-04-01 – 1998-03-31: -18115402 USD Inspect Net Income Open source 1997-04-01 – 1998-03-31: -10815150 USD Inspect Operating Cash Flow Open source 1997-04-01 – 1998-03-31: 238841 USD Inspect Capital Expenditure Open source
1999 1998-04-01 – 1999-03-31	22289063	37071923 Derived	-14782860	0 Derived	-14782860	-24120040 Derived	Source 1998-04-01 – 1999-03-31: 22289063 USD Inspect Revenue Open source 1998-04-01 – 1999-03-31: -14782860 USD Inspect Operating Income Open source 1998-04-01 – 1999-03-31: -14782860 USD Inspect Net Income Open source 1998-04-01 – 1999-03-31: -23233200 USD Inspect Operating Cash Flow Open source 1998-04-01 – 1999-03-31: 886840 USD Inspect Capital Expenditure Open source
2000 1999-04-01 – 2000-03-31	6492868	35864772 Derived	-29371904	-1776000 Derived	-27595904	-8497507 Derived	Source 1999-04-01 – 2000-03-31: 6492868 USD Inspect Revenue Open source 1999-04-01 – 2000-03-31: -29371904 USD Inspect Operating Income Open source 1999-04-01 – 2000-03-31: -27595904 USD Inspect Net Income Open source 1999-04-01 – 2000-03-31: -7706936 USD Inspect Operating Cash Flow Open source 1999-04-01 – 2000-03-31: 790571 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 6.5M 2000

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19971997-03-31	Revenue	0	Revenue: 0 Open source
19981998-03-31	Revenue	0	Revenue: 0 Open source
19991999-03-31	Revenue	22289063	Revenue: 22289063 Open source
20002000-03-31	Revenue	6492868	Revenue: 6492868 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-70.9% 2000

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19971997-03-31	Year over year	No prior comparable period	Revenue: 0 Open source
19981998-03-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
19991999-03-31	Year over year	No prior comparable period	Revenue: 22289063 Open source Revenue: 0 Open source
20002000-03-31	Year over year	-70.9%	Revenue: 6492868 Open source Revenue: 22289063 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -452.4% 2000

Net margin -425% 2000

Free cash flow margin -130.9% 2000

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
1997-03-31	Operating margin	Not reported	Revenue: 0 Open source
19981998-03-31	Operating margin	Not reported	Operating Income: -18115402 Open source Revenue: 0 Open source
19991999-03-31	Operating margin	-66.3%	Operating Income: -14782860 Open source Revenue: 22289063 Open source
20002000-03-31	Operating margin	-452.4%	Operating Income: -29371904 Open source Revenue: 6492868 Open source
19971997-03-31	Net margin	Not reported	Net Income: -11232852 Open source Revenue: 0 Open source
19981998-03-31	Net margin	Not reported	Net Income: -18115402 Open source Revenue: 0 Open source
19991999-03-31	Net margin	-66.3%	Net Income: -14782860 Open source Revenue: 22289063 Open source
20002000-03-31	Net margin	-425%	Net Income: -27595904 Open source Revenue: 6492868 Open source
19971997-03-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -5366039 Open source
19981998-03-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -10815150 Open source Capital Expenditure: 238841 Open source
19991999-03-31	Free cash flow margin	-108.2%	Revenue: 22289063 Open source Operating Cash Flow: -23233200 Open source Capital Expenditure: 886840 Open source
20002000-03-31	Free cash flow margin	-130.9%	Revenue: 6492868 Open source Operating Cash Flow: -7706936 Open source Capital Expenditure: 790571 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -7.7M 2000

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19971997-03-31	Operating cash flow	-5366039	Operating Cash Flow: -5366039 Open source
19981998-03-31	Operating cash flow	-10815150	Operating Cash Flow: -10815150 Open source
19991999-03-31	Operating cash flow	-23233200	Operating Cash Flow: -23233200 Open source
20002000-03-31	Operating cash flow	-7706936	Operating Cash Flow: -7706936 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -8.5M 2000

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19971997-03-31	Free cash flow	Unavailable	Operating Cash Flow: -5366039 Open source
19981998-03-31	Free cash flow	-11053991	Operating Cash Flow: -10815150 Open source Capital Expenditure: 238841 Open source
19991999-03-31	Free cash flow	-24120040	Operating Cash Flow: -23233200 Open source Capital Expenditure: 886840 Open source
20002000-03-31	Free cash flow	-8497507	Operating Cash Flow: -7706936 Open source Capital Expenditure: 790571 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1997-03-31	Liabilities / assets	Not reported	Total Assets: 8831920 Open source
1998-03-31	Liabilities / assets	Not reported	Total Assets: 25439085 Open source
1999-03-31	Liabilities / assets	Not reported	Total Assets: 23520523 Open source
20002000-03-31	Liabilities / assets	Not reported	Total Liabilities: 14591144 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.16× 2000

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19971997-03-31	Current assets / current liabilities	7.77×	Current Assets: 8507665 Open source Current Liabilities: 1094596 Open source
19981998-03-31	Current assets / current liabilities	3.25×	Current Assets: 24640922 Open source Current Liabilities: 7579775 Open source
19991999-03-31	Current assets / current liabilities	1.15×	Current Assets: 21999646 Open source Current Liabilities: 19166560 Open source
20002000-03-31	Current assets / current liabilities	0.16×	Current Assets: 2379942 Open source Current Liabilities: 14453792 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1997 1996-04-01 – 1997-03-31	−USD 11.23 million Exact value Exact value: -11232852 USD 1996-04-01 – 1997-03-31: -11232852 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMAPRINT INC · 1997-03-31 PHARMAPRINT INC (edgar:935155) Net Income: -11232852 USD Concept: fundies:NetIncome Period: 1996-04-01 to 1997-03-31 Values: Latest reported Published: 2026-11-02T17:09:03Z Snapshot: 8f4a855d1da598c97fea856ec291401e8f8c230fd62edd4d12fc3e4f6d9bca21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/935155/explain?concept=fundies%3ANetIncome&period=1997-03-31&surface=latest&period_type=duration&start=1996-04-01&unit=USD&dimensions= Input fundies:NetIncome: -11232852 USD (1996-04-01 to 1997-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/935155/0001047469-99-025831.txt#2143 The citation records this snapshot. The page link may show a newer release later.	−USD 5.37 million Exact value Exact value: -5366039 USD 1996-04-01 – 1997-03-31: -5366039 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMAPRINT INC · 1997-03-31 PHARMAPRINT INC (edgar:935155) Operating Cash Flow: -5366039 USD Concept: fundies:OperatingCashFlow Period: 1996-04-01 to 1997-03-31 Values: Latest reported Published: 2026-11-02T17:09:03Z Snapshot: 8f4a855d1da598c97fea856ec291401e8f8c230fd62edd4d12fc3e4f6d9bca21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/935155/explain?concept=fundies%3AOperatingCashFlow&period=1997-03-31&surface=latest&period_type=duration&start=1996-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5366039 USD (1996-04-01 to 1997-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/935155/0001047469-99-025831.txt#2159 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1998 1997-04-01 – 1998-03-31	−USD 18.12 million Exact value Exact value: -18115402 USD 1997-04-01 – 1998-03-31: -18115402 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMAPRINT INC · 1998-03-31 PHARMAPRINT INC (edgar:935155) Net Income: -18115402 USD Concept: fundies:NetIncome Period: 1997-04-01 to 1998-03-31 Values: Latest reported Published: 2026-11-02T17:09:03Z Snapshot: 8f4a855d1da598c97fea856ec291401e8f8c230fd62edd4d12fc3e4f6d9bca21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/935155/explain?concept=fundies%3ANetIncome&period=1998-03-31&surface=latest&period_type=duration&start=1997-04-01&unit=USD&dimensions= Input fundies:NetIncome: -18115402 USD (1997-04-01 to 1998-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/935155/0001095811-00-002886.txt#2479 The citation records this snapshot. The page link may show a newer release later.	−USD 10.82 million Exact value Exact value: -10815150 USD 1997-04-01 – 1998-03-31: -10815150 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMAPRINT INC · 1998-03-31 PHARMAPRINT INC (edgar:935155) Operating Cash Flow: -10815150 USD Concept: fundies:OperatingCashFlow Period: 1997-04-01 to 1998-03-31 Values: Latest reported Published: 2026-11-02T17:09:03Z Snapshot: 8f4a855d1da598c97fea856ec291401e8f8c230fd62edd4d12fc3e4f6d9bca21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/935155/explain?concept=fundies%3AOperatingCashFlow&period=1998-03-31&surface=latest&period_type=duration&start=1997-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10815150 USD (1997-04-01 to 1998-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/935155/0001095811-00-002886.txt#2495 The citation records this snapshot. The page link may show a newer release later.	USD 238,841 Exact value Exact value: 238841 USD 1997-04-01 – 1998-03-31: 238841 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PHARMAPRINT INC · 1998-03-31 PHARMAPRINT INC (edgar:935155) Capital Expenditure: 238841 USD Concept: fundies:CapitalExpenditure Period: 1997-04-01 to 1998-03-31 Values: Latest reported Published: 2026-11-02T17:09:03Z Snapshot: 8f4a855d1da598c97fea856ec291401e8f8c230fd62edd4d12fc3e4f6d9bca21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/935155/explain?concept=fundies%3ACapitalExpenditure&period=1998-03-31&surface=latest&period_type=duration&start=1997-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 238841 USD (1997-04-01 to 1998-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/935155/0001095811-00-002886.txt#2499 The citation records this snapshot. The page link may show a newer release later.	−USD 11.05 million Calculation and evidence -10815150 − 238841 USD Exact free cash flow: -11053991 USD 1997-04-01 – 1998-03-31: -10815150 USD · Inspect Operating Cash Flow · Source 1997-04-01 – 1998-03-31: 238841 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PHARMAPRINT INC · 1998-03-31 PHARMAPRINT INC (edgar:935155) Free cash flow: -11053991 USD Concept: free-cash-flow Period: 1997-04-01 to 1998-03-31 Values: Latest reported Published: 2026-11-02T17:09:03Z Snapshot: 8f4a855d1da598c97fea856ec291401e8f8c230fd62edd4d12fc3e4f6d9bca21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/935155?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -10815150 USD (1997-04-01 to 1998-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/935155/0001095811-00-002886.txt#2495 Input fundies:CapitalExpenditure: 238841 USD (1997-04-01 to 1998-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/935155/0001095811-00-002886.txt#2499 The citation records this snapshot. The page link may show a newer release later.
1999 1998-04-01 – 1999-03-31	−USD 14.78 million Exact value Exact value: -14782860 USD 1998-04-01 – 1999-03-31: -14782860 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMAPRINT INC · 1999-03-31 PHARMAPRINT INC (edgar:935155) Net Income: -14782860 USD Concept: fundies:NetIncome Period: 1998-04-01 to 1999-03-31 Values: Latest reported Published: 2026-11-02T17:09:03Z Snapshot: 8f4a855d1da598c97fea856ec291401e8f8c230fd62edd4d12fc3e4f6d9bca21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/935155/explain?concept=fundies%3ANetIncome&period=1999-03-31&surface=latest&period_type=duration&start=1998-04-01&unit=USD&dimensions= Input fundies:NetIncome: -14782860 USD (1998-04-01 to 1999-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/935155/0001095811-00-002886.txt#2479 The citation records this snapshot. The page link may show a newer release later.	−USD 23.23 million Exact value Exact value: -23233200 USD 1998-04-01 – 1999-03-31: -23233200 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMAPRINT INC · 1999-03-31 PHARMAPRINT INC (edgar:935155) Operating Cash Flow: -23233200 USD Concept: fundies:OperatingCashFlow Period: 1998-04-01 to 1999-03-31 Values: Latest reported Published: 2026-11-02T17:09:03Z Snapshot: 8f4a855d1da598c97fea856ec291401e8f8c230fd62edd4d12fc3e4f6d9bca21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/935155/explain?concept=fundies%3AOperatingCashFlow&period=1999-03-31&surface=latest&period_type=duration&start=1998-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -23233200 USD (1998-04-01 to 1999-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/935155/0001095811-00-002886.txt#2495 The citation records this snapshot. The page link may show a newer release later.	USD 886,840 Exact value Exact value: 886840 USD 1998-04-01 – 1999-03-31: 886840 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PHARMAPRINT INC · 1999-03-31 PHARMAPRINT INC (edgar:935155) Capital Expenditure: 886840 USD Concept: fundies:CapitalExpenditure Period: 1998-04-01 to 1999-03-31 Values: Latest reported Published: 2026-11-02T17:09:03Z Snapshot: 8f4a855d1da598c97fea856ec291401e8f8c230fd62edd4d12fc3e4f6d9bca21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/935155/explain?concept=fundies%3ACapitalExpenditure&period=1999-03-31&surface=latest&period_type=duration&start=1998-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 886840 USD (1998-04-01 to 1999-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/935155/0001095811-00-002886.txt#2499 The citation records this snapshot. The page link may show a newer release later.	−USD 24.12 million Calculation and evidence -23233200 − 886840 USD Exact free cash flow: -24120040 USD 1998-04-01 – 1999-03-31: -23233200 USD · Inspect Operating Cash Flow · Source 1998-04-01 – 1999-03-31: 886840 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PHARMAPRINT INC · 1999-03-31 PHARMAPRINT INC (edgar:935155) Free cash flow: -24120040 USD Concept: free-cash-flow Period: 1998-04-01 to 1999-03-31 Values: Latest reported Published: 2026-11-02T17:09:03Z Snapshot: 8f4a855d1da598c97fea856ec291401e8f8c230fd62edd4d12fc3e4f6d9bca21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/935155?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -23233200 USD (1998-04-01 to 1999-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/935155/0001095811-00-002886.txt#2495 Input fundies:CapitalExpenditure: 886840 USD (1998-04-01 to 1999-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/935155/0001095811-00-002886.txt#2499 The citation records this snapshot. The page link may show a newer release later.
2000 1999-04-01 – 2000-03-31	−USD 27.6 million Exact value Exact value: -27595904 USD 1999-04-01 – 2000-03-31: -27595904 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMAPRINT INC · 2000-03-31 PHARMAPRINT INC (edgar:935155) Net Income: -27595904 USD Concept: fundies:NetIncome Period: 1999-04-01 to 2000-03-31 Values: Latest reported Published: 2026-11-02T17:09:03Z Snapshot: 8f4a855d1da598c97fea856ec291401e8f8c230fd62edd4d12fc3e4f6d9bca21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/935155/explain?concept=fundies%3ANetIncome&period=2000-03-31&surface=latest&period_type=duration&start=1999-04-01&unit=USD&dimensions= Input fundies:NetIncome: -27595904 USD (1999-04-01 to 2000-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/935155/0001095811-00-002886.txt#2479 The citation records this snapshot. The page link may show a newer release later.	−USD 7.71 million Exact value Exact value: -7706936 USD 1999-04-01 – 2000-03-31: -7706936 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMAPRINT INC · 2000-03-31 PHARMAPRINT INC (edgar:935155) Operating Cash Flow: -7706936 USD Concept: fundies:OperatingCashFlow Period: 1999-04-01 to 2000-03-31 Values: Latest reported Published: 2026-11-02T17:09:03Z Snapshot: 8f4a855d1da598c97fea856ec291401e8f8c230fd62edd4d12fc3e4f6d9bca21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/935155/explain?concept=fundies%3AOperatingCashFlow&period=2000-03-31&surface=latest&period_type=duration&start=1999-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7706936 USD (1999-04-01 to 2000-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/935155/0001095811-00-002886.txt#2495 The citation records this snapshot. The page link may show a newer release later.	USD 790,571 Exact value Exact value: 790571 USD 1999-04-01 – 2000-03-31: 790571 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PHARMAPRINT INC · 2000-03-31 PHARMAPRINT INC (edgar:935155) Capital Expenditure: 790571 USD Concept: fundies:CapitalExpenditure Period: 1999-04-01 to 2000-03-31 Values: Latest reported Published: 2026-11-02T17:09:03Z Snapshot: 8f4a855d1da598c97fea856ec291401e8f8c230fd62edd4d12fc3e4f6d9bca21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/935155/explain?concept=fundies%3ACapitalExpenditure&period=2000-03-31&surface=latest&period_type=duration&start=1999-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 790571 USD (1999-04-01 to 2000-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/935155/0001095811-00-002886.txt#2499 The citation records this snapshot. The page link may show a newer release later.	−USD 8.5 million Calculation and evidence -7706936 − 790571 USD Exact free cash flow: -8497507 USD 1999-04-01 – 2000-03-31: -7706936 USD · Inspect Operating Cash Flow · Source 1999-04-01 – 2000-03-31: 790571 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PHARMAPRINT INC · 2000-03-31 PHARMAPRINT INC (edgar:935155) Free cash flow: -8497507 USD Concept: free-cash-flow Period: 1999-04-01 to 2000-03-31 Values: Latest reported Published: 2026-11-02T17:09:03Z Snapshot: 8f4a855d1da598c97fea856ec291401e8f8c230fd62edd4d12fc3e4f6d9bca21 Dimensions: Consolidated View: https://fundies.io/companies/edgar/935155?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7706936 USD (1999-04-01 to 2000-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/935155/0001095811-00-002886.txt#2495 Input fundies:CapitalExpenditure: 790571 USD (1999-04-01 to 2000-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/935155/0001095811-00-002886.txt#2499 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

20 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000935155, 935155, edgar:935155

Also known as ABT GLOBAL PHARMACEUTICAL CORP

PHARMAPRINT INC

Latest quarter

Revenue

Net margin

Operating cash flow

Trailing twelve months

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2000 1999-04-01 – 2000-03-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation